Methodological Concerns and Interpretive Limitations in “Transvenous Lead Extraction Outcomes in Hemodialysis Patients”

The recently published article “Transvenous Lead Extraction Outcomes in Hemodialysis Patients: Markers for Increased Mortality” by Paul et al. addresses a significant clinical question regarding procedural outcomes in a vulnerable population. However, several methodological issues limit the reliability and generalizability of the findings. The most notable concern is the very small sample size of the dialysis subgroup (n = 53), which represents only 3.3% of the total cohort, and an even smaller subgroup of patients with infectious indications (n = 48). Such a limited cohort size substantially reduces statistical power and increases the potential for type II error. Additionally, it raises questions about the robustness of the multivariable modeling given the small number of observed outcome events. The study's retrospective and single-center design introduces selection and information bias. This is particularly concerning because data were extracted from electronic medical records without consistent definitions or independent evaluation of complications and mortality. Additionally, the multivariate Cox model seems to be overfitted, as it includes multiple predictors despite a limited number of deaths, which can lead to model instability and false associations. Moreover, the claim that dialysis is an independent predictor of 30-day mortality may be exaggerated, as significant unmeasured confounding factors, such as dialysis adequacy, type of vascular access, nutritional status, and systemic inflammatory markers, were not taken into account in the analysis [1]. Another limitation is the incomplete characterization of infection-related variables. The study does not differentiate between vegetation, thrombus, or fibrin sheath, nor does it provide microbiological stratification by pathogen type [2]. This lack of differentiation weakens the understanding of the relationship between intracardiac masses and mortality. Additionally, the echocardiographic criteria used to identify these masses were not standardized across different operators or imaging modalities, which further diminishes the internal validity of the findings [3]. The study could have been improved by using a prospective, multicenter design with standardized imaging and microbiological protocols, which would enhance both reproducibility and external validity. Incorporating propensity score matching could have improved the comparability of baseline characteristics between the dialysis and nondialysis groups [4]. Additionally, including interaction terms between infection status and dialysis could have clarified whether these factors work together to increase the risk of mortality. Analyzing long-term outcomes, such as mortality at 90 days or 1 year, would also have provided a clearer understanding of the temporal relationship between transvenous lead extraction and adverse events [5]. Despite these limitations, the authors highlight a clinically relevant association between hemodialysis, infection, and early mortality following lead extraction. Future research should aim to validate these findings in larger, prospective cohorts, ideally integrating advanced imaging, microbiological, and inflammatory profiling to better define risk stratification and guide procedural decision-making in this high-risk population. Both authors confirm substantial contributions to the conception, drafting, and critical revision of this letter; final approval of the version to be submitted; and agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved, in accordance with ICMJE authorship criteria. The authors have nothing to report. The author declare no conflicts of interest.